However, further studies are warranted to further validate the effects of HIF-1 on the angiogenesis of HCC in hypoxic state to confirm the possibility of HIF-1 as a therapeutic target in HCC. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.